Marginal lung donors: A diminishing margin of safety?

Transplantation

Volumn 82, Issue 10, 2006, Pages 1273-1279

  Botha, Phil ^a   Fisher, Andrew J ^a   Dark, John H ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Donor selection; Lung transplantation; Tissue donors

Indexed keywords

AGE; ARTERIAL OXYGEN TENSION; BRONCHOSCOPY; CADAVER; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; LUNG EDEMA; LUNG GAS EXCHANGE; LUNG INFECTION; LUNG INFILTRATE; LUNG TRANSPLANTATION; MEDICAL SOCIETY; NONHUMAN; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; REVIEW; SAFETY; SMOKING; THORAX RADIOGRAPHY;

HUMANS; LUNG; MIDDLE AGED; OXYGEN; PATIENT SELECTION; RADIOGRAPHY, THORACIC; SAFETY; SMOKING; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 33751543448     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000236099.52382.74     Document Type: Review

References (71)

1. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 2005; 24(8): 956.
2. Transplant Activity in the United Kingdom 2004-2005. Bristol, UK: UK Transplant Activity Report, 2005.
3. Ganesh JS, Rogers CA, Banner NR, Bonser RS. Donor cause of death and mid-term survival in lung transplantation. J Heart Lung Transplant 2005; 24(10): 1544.
4. Pierson RN, Barr ML, McCullough KP, et al. Thoracic organ transplantation. Am J Transplant 2004; 4(s9): 93-105.
5. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109(6): 1075-1079.
6. Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003; 22(11): 1183.
7. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005; 24(8): 945.
8. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000; 19(12): 1199.
9. Aigner C, Winkler G, Jaksch P, et al. Extended donor criteria for lung transplantation-a clinical reality. Eur J Cardiothorac Surg 2005; 27(5): 757.
10. Kawut SM, Reyentovich A, Wilt JS, et al. Outcomes of extended donor lung recipients after lung transplantation. Transplantation 2005; 79(3): 310.
11. Botha P, Trivedi D, Weir CJ, et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006; 131(5): 1154.
12. Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002; 123(3): 421.
13. Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002; 360(9333): 619.
14. Fisher AJ, Donnelly SC, Pritchard G, et al. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 2004; 59(5): 434.
15. Snell GI, Griffiths A, Macfarlane L, et al. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant 2000; 19(4): 401.
16. de Perrot M, Weder W, Patterson GA, Keshavjee S. Strategies to increase limited donor resources. Eur Respir J 2004; 23(3): 477.
17. Fischer S, Gohrbandt B, Struckmeier P, et al. Lung transplantation with lungs from donors fifty years of age and older. J Thorac Cardiovasc Surg 2005; 129(4): 919.
18. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999; 18(5): 425.
19. Oppenheimer F, Aljama P, Asensio Peinado C, et al. The impact of donor age on the results of renal transplantation. Nephrol Dialysis Transplant 2004; 19 Suppl 3: iii11-5.
20. Cuende N, Miranda B, Canon JF, et al. Donor characteristics associated with liver graft survival. Transplantation 2005; 79(10): 1445.
21. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124(4): 1232.
22. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report-2004. J Heart Lung Transplant 2004; 23(7): 804.
23. Thabut G, Mal H, Cerrina J, et al. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant 2005; 24(9): 1347.
24. Luckraz H, White P, Sharples LD, et al. Short- and long-term outcomes of using pulmonary allograft donors with low Po2. J Heart Lung Transplant 2005; 24(4): 470.
25. Aziz TM, El-Gamel A, Saad RA, et al. Pulmonary vein gas analysis for assessing donor lung function. Ann Thorac Surg 2002; 73(5): 1599-1604.
26. McGiffin DC, Zorn JGL, Young JKR, et al. The Intensive Care Unit Oxygen Challenge Should Not Be Used for Donor Lung Function Decision-making. J Heart Lung Transplant 2005; 24(11): 1902.
27. Ware LB, Fang X, Wang Y, et al. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant 2005; 24(10): 1650.
28. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005; 127(6): 1977.
29. Vaporciyan AA, Merriman KW, Ece F, et al. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg 2002; 73(2): 420-425.
30. Lin SJ, Koford JK, Baird BC, et al. Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation 2005; 80(4): 482.
31. Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G, et al. A prospective study of tobacco smoking as a predictor of complications in general surgery. Infect Control Hospital Epidemiol 2003; 24(1): 37.
32. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359(9301): 114.
33. Oto T, Griffiths AP, Levvey B, et al. A donor history of smoking affects early but not late outcome in lung transplantation. Transplantation 2004; 78(4): 599.
34. Shumway SJ, Hertz MI, Petty MG, Bolman RM, 3rd. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 1994; 57(1): 92-95.
35. Straznicka M, Follette DM, Eisner MD, et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002; 124(2): 250.
36. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160(1): 265.
37. Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005; 5(4 Pt 1): 684.
38. Maron MB, Holcomb PH, Dawson CA, et al. Edema development and recovery in neurogenic pulmonary edema. J Appl Physiol 1994; 77(3): 1155.
39. Fiser SM, Kron IL, Long SM, et al. Donor lung salvage after neurogenic pulmonary edema with the use of post-transplant extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2001; 122(6): 1257.
40. Bolton JS, Padia SA, Borja MC, et al. The predictive value and interobserver variability of donor chest radiograph interpretation in lung transplantation. Eur J Cardiothorac Surg 2003; 23(4): 484.
41. McCowin MJ, Hall TS, Babcock WD, et al. Changes in radiographic abnormalities in organ donors: associations with lung transplantation. J Heart Lung Transplant 2005; 24(3): 323.
42. Weill D, Dey GC, Hicks RA, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21(5): 555.
43. Avlonitis VS, Krause A, Luzzi L, et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003; 24(4): 601.
44. Lardinois D, Banysch M, Korom S, et al. Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg 2005; 27(5): 762.
45. Riou B, Guesde R, Jacquens Y, Duranteau R, Viars P. Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med 1994; 150(2): 558.
46. Weill D. Donor criteria in lung transplantation: an issue revisited. Chest 2002; 121(6): 2029.
47. Thabut G, Mal H, Cerrina J, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005; 171(7): 786.
48. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17(4): 423.
49. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75(4): 482.
50. Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2(8): 761.
51. Mukadam ME, Harrington DK, Wilson IC, et al. Does donor catecholamine administration affect early lung function after transplantation? J Thoracic Cardiovasc Surg 2005; 130(3): 926.
52. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59(1): 58.
53. Ware LB, Fang X, Wang Y, et al. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002; 93(5): 1869.
54. Michard F, Schachtrupp A, Toens C. Factors influencing the estimation of extravascular lung water by transpulmonary thermodilution in critically ill patients. Crit Care Med 2005; 33(6): 1243.
55. Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001; 163(1): 259.
56. Kaneda H, Waddell TK, Liu M, Keshavjee S. Dynamic changes in cytokine gene expression during cold ischemia predicts outcome after lung transplantation in humans. J Heart Lung Transplant 2005; 24 (2 Suppl 1): S79.
57. Kaneda H, Gutierrez C, de Perrot M, et al. Pre-implantation multiple cytokine mRNA expression analysis in donor lung grafts predicts survival after lung transplantation in humans. J Heart Lung Transplant 2004; 23(2 Supp 1): S49-S50.
58. Rega FR, Vanaudenaerde BM, Wuyts WA, et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2005; 24(1): 20.
59. Oto T, Griffiths A, Levvey B, et al. Donor history of asthma is not a contraindication to lung transplantation: 12-year single-center experience. J Heart Lung Transplant 2004; 23(3): 309.
60. Fischer S, Gohrbandt B, Meyer A, et al. Should lungs from donors with severe acute pulmonary embolism be accepted for transplantation? The Hannover experience. J Thorac Cardiovasc Surg 2003; 126(5): 1641.
61. Luckraz H, Tsui SS, Parameshwar J, et al. Improved outcome with organs from carbon monoxide poisoned donors for intrathoracic transplantation. Ann Thorac Surg 2001; 72(3): 709.
62. Silva JA, Chamorro C, Varela A, et al. Successful bilateral lung transplantation from a methanol-poisoned donor. Transplant Proc 2004; 36(9): 2806.
63. Evrard P, Hantson P, Ferrant E, et al. Successful double lung transplantation with a graft obtained from a methanol-poisoned donor. Chest 1999; 115(5): 1458.
64. Caballero F, Lopez-Navidad A, Cotorruelo J, Txoperena G. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation. Transplantation 2002; 74(4): 532.
65. McNamee CJ, Modry DL, Lien D, Conlan AA. Drowned donor lung for bilateral lung transplantation. J Thorac Cardiovasc Surg 2003; 126(3): 910.
66. Keshavjee S, Davis RD, Zamora MR, et al. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 2005; 129(2): 423.
67. Dahlberg PS, Prekker ME, Herrington CS, et al. Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation. J Heart Lung Transplant 2004; 23(8): 979.
68. Hartwig MG, Appel JZ, 3rd, Cantu E, 3rd, et al. Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation. Ann Thorac Surg 2005; 80(5): 1872-1879.
69. Oto T, Rosenfeldt F, Rowland M, et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg 2004; 78(4): 1230.
70. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20(5): 518.
71. Orens JB, Shearon TH, Freudenburger RS, et al. Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant 2006; 6(5 Pt 2): 1188.